Home
Resources
Diseases
Training
SYSVAC
About
Registry
E-learning courses
News
Events
Network
Vision and Mission
Steering Committee
Map
Meetings
Join us
Home
Resources
Resources
Selected
COVID-19
Human papillomavirus (HPV)
2024
2021
2013
Europe
Clear all
Type of publications
NITAG documentation
(76)
Scientific publications
(1)
Systematic reviews (SYSVAC)
(4)
Topics
Available to download in languages
Regions
Europe
(81)
Africa
(20)
Americas
(72)
South-East Asia
(4)
Western Pacific
(17)
Countries
Belgium
(15)
Denmark
(1)
France
(18)
Germany
(8)
Ireland
(7)
Netherlands
(6)
Spain
(3)
Sweden
(2)
United Kingdom
(20)
Diseases
COVID-19
(77)
Human papillomavirus (HPV)
(4)
Dengue
(1)
Diphtheria
(1)
Hepatitis A
(2)
Hepatitis B
(3)
Herpes zoster
(1)
Influenza
(8)
Measles
(2)
Meningococcal disease
(2)
Pertussis
(1)
Pneumococcal disease
(3)
Rotavirus
(3)
Streptococcus group B
(1)
Tetanus
(1)
Varicella
(2)
Vaccine topics
Acceptance
(2)
Coverage
(3)
Economic aspects
(1)
Ethical issues
(1)
Target population
Adolescents
(1)
Adults
(2)
All age groups
(3)
Healthcare workers
(1)
Older adults
(1)
Pregnant women
(1)
Risk group
(2)
Publication date
2024
(1)
2021
(77)
2013
(3)
2023
(14)
2022
(38)
2020
(21)
2019
(6)
2018
(7)
2017
(9)
2016
(3)
2015
(4)
2014
(7)
2012
(1)
2011
(2)
2010
(1)
2009
(2)
2008
(2)
2007
(3)
81 results found
2021
∙
NIAC
NIAC Recommendations on COVID-19 vaccination for children aged 5 to 11 Years
2021
∙
NIAC
NIAC UPDATED RECOMMENDATIONS FOR COVID-19 VACCINATION IN PREGNANCY
2021
∙
Conseil Supérieur de la Santé (CSS)
Non-replicating viral vector vaccines and the Belgian COVID-19 vaccination strategy
2021
∙
JCVI
Optimising the COVID-19 vaccination programme for maximum short-term impact
2021
∙
Haut Conseil de la santé publique
Potential impact of the circulation of SARS-CoV-2 variants on the COVID - 19 strategy - 9 April, 2021
2021
∙
Conseil Supérieur de la Santé (CSS)
Prioritization of at-risk groups for SARS-CoV-2 Vaccination (Phase 1b)
2021
∙
Haut Conseil de la santé publique
Priority vaccination of the entourage of people immunocompromised against SARS-Cov 2 - 30 April, 2021
2021
∙
Folkhälsomyndigheten
Recommendation for continued vaccination of priority groups
2021
∙
Conseil Supérieur de la Santé (CSS)
Recommendations for the administration of one or two doses of mRNA vaccines in people who are or have been infected with SARS-CoV-2 in Belgium - 09 June 2021
2021
∙
NIAC
RECOMMENDATIONS FOR THE ROLE OF COVID-19 HETEROLOGOUS VACCINATION IN THE NATIONAL PROGRAMME
Home
Resources
Diseases
Training
SYSVAC
News
Events
Network
Sign in / Register